Home > Journals > Minerva Gastroenterology > Past Issues > Minerva Gastroenterologica e Dietologica 2020 December;66(4) > Minerva Gastroenterologica e Dietologica 2020 December;66(4):307-20



Publishing options
To subscribe
Submit an article
Recommend to your librarian


Publication history
Cite this article as



Minerva Gastroenterologica e Dietologica 2020 December;66(4):307-20

DOI: 10.23736/S1121-421X.20.02738-5


language: English

Hepatic steatosis integrated approach: nutritional guidelines and joined nutraceutical administration

Beniamino PALMIERI 1, 2, Veronica CORAZZARI 1, 2 , Diana G. PANARIELLO BRASILE 1, Vincenzo SANGIOVANNI 3, Maria VADALÀ 1

1 Second Opinion Medical Network, Modena, Italy; 2 Medico Cura Te Stesso Onlus, Modena, Italy; 3 Department of Infectivology, Cotugno Hospital, Naples, Italy

BACKGROUND: The nonalcoholic fat liver disease (NAFLD) progresses in 30% of the patients to not alcoholic steatohepatitis (NASH) and subsequently in liver fibrosis and even primary cancer and death. Due to the complex physiopathology of the liver steatosis, NASH is an area orphan of specific drugs, but many authors suggest an integrated treatment based upon diet, lifestyle change, and pharmacology.
METHODS: Our clinical study selected from a wider patient cohort, 13 subjects, appealing to the Second Opinion Medical Consulting Network, for liver and nutritional problems. The diet was integrated with regular prescription of an herbal derivative based on Chrysanthellum americanum and Pistacia lentiscus L. extracts. Clinical data of the recruited patients including body weight, Body Mass Index, were recorded before and after treatment. Each patient underwent pre-post accurate clinical examination and lab exams. The liver stiffness and liver steatosis were evaluated by a trained hepatologist with FibroScan®.
RESULTS: A significant reduction of anthropometric parameters was detected in all the patients at the end of the study; liver fibrosis and steatosis were instrumentally decreased in 8 subjects, but not significant changes in lab exams and no adverse effects were reported.
CONCLUSIONS: Chrysanthellum americanum and Pistacia lentiscus L. extracts were absolutely safe and effective and gave a substantial contribution to the life quality benefit, metabolic balance and gut function in patients with hepatic steatosis.

KEY WORDS: Fatty liver; Nutritional sciences; Dietary supplements; Pistacia; Non-alcoholic fatty liver disease

top of page